Deirdre McMenamin

1.1k total citations · 1 hit paper
14 papers, 816 citations indexed

About

Deirdre McMenamin is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Deirdre McMenamin has authored 14 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Genetics and 2 papers in Infectious Diseases. Recurrent topics in Deirdre McMenamin's work include Virus-based gene therapy research (10 papers), CRISPR and Genetic Engineering (7 papers) and RNA Interference and Gene Delivery (3 papers). Deirdre McMenamin is often cited by papers focused on Virus-based gene therapy research (10 papers), CRISPR and Genetic Engineering (7 papers) and RNA Interference and Gene Delivery (3 papers). Deirdre McMenamin collaborates with scholars based in United States and China. Deirdre McMenamin's co-authors include James M. Wilson, Lili Wang, Peter Bell, Zhenning He, Hongwei Yu, Yang Yang, John White, Mark L. Batshaw, Hiroki Morizono and Chenyu Xu and has published in prestigious journals such as Blood, Nature Biotechnology and The Journal of Immunology.

In The Last Decade

Deirdre McMenamin

14 papers receiving 803 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice

2016 433 citations Yang Yang, Lili Wang et al. Nature Biotechnology profile →

Peers

Countries citing papers authored by Deirdre McMenamin

Since Specialization

Citations

This map shows the geographic impact of Deirdre McMenamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deirdre McMenamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deirdre McMenamin more than expected).

Fields of papers citing papers by Deirdre McMenamin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deirdre McMenamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deirdre McMenamin. The network helps show where Deirdre McMenamin may publish in the future.

Co-authorship network of co-authors of Deirdre McMenamin

This figure shows the co-authorship network connecting the top 25 collaborators of Deirdre McMenamin. A scholar is included among the top collaborators of Deirdre McMenamin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deirdre McMenamin. Deirdre McMenamin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	DWI Metrics Differentiating Benign Intraductal Papillary Mucinous Neoplasms from Invasive Pancreatic Cancer: A Study in GEM Models 2022 ·Cancers ·(unknown), Emma E. Furth, Yong Fan, (unknown), Stephen Pickup, Jianbo Cao, Hoon Choi, (unknown), Quy Cao, Russell T. Shinohara, Deirdre McMenamin, Cynthia Clendenin, Thomas B. Karasic, Jeffrey Duda, James C. Gee, Peter J. O’Dwyer, Mark Rosen, Rong Zhou	7
2	A mutation-independent CRISPR-Cas9–mediated gene targeting approach to treat a murine model of ornithine transcarbamylase deficiency 2020 ·Science Advances ·Lili Wang, Yang Yang, Camilo Breton, Peter Bell, Mingyao Li, Jia Zhang, Yan Che, (unknown), Zhenning He, John White, (unknown), Chenyu Xu, Deirdre McMenamin, Hongwei Yu, Hiroki Morizono, Mark L. Batshaw, James M. Wilson	53
3	Adeno-associated virus-mediated expression of human butyrylcholinesterase to treat organophosphate poisoning 2019 ·PLoS ONE ·Vibhor Gupta, C. Linn Cadieux, Deirdre McMenamin, (unknown), Muhammad Arif, (unknown), (unknown), (unknown), Yan Che, Tamara Goode, Maria P. Limberis, Mingyao Li, Douglas M. Cerasoli, Anna P. Tretiakova, James M. Wilson	6
4	CRISPR/Cas9-mediated in vivo gene targeting corrects hemostasis in newborn and adult factor IX–knockout mice 2019 ·Blood ·Lili Wang, Yang Yang, Camilo Breton, John White, Jia Zhang, Yan Che, (unknown), Deirdre McMenamin, Zhenning He, (unknown), Mingyao Li, James M. Wilson	62
5	Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar Syndrome 2018 ·Molecular Therapy — Methods & Clinical Development ·Jenny A. Greig, (unknown), Christine Draper, Deirdre McMenamin, (unknown), Peter Bell, John T. Gray, Laura K. Richman, James M. Wilson	11
6	Alternative Start Sites Downstream of Non-Sense Mutations Drive Antigen Presentation and Tolerance Induction to C-Terminal Epitopes 2017 ·The Journal of Immunology ·(unknown), Suryanarayan Somanathan, Christian Hinderer, (unknown), Deirdre McMenamin, Christine Draper, James M. Wilson	1
7	760. Optimized AAV-Mediated Human Factor VIII Gene Therapy in Hemophilia A Mice and Cynomolgus Macaques 2016 ·Molecular Therapy ·Jenny A. Greig, Qiang Wang, (unknown), Erin Bote, Deirdre McMenamin, Christine Draper, Shu‐Jen Chen, Alexandra L. Hanlon, Tamara Goode, K. Reed Clark, Samuel C. Wadsworth, Lili Wang, James M. Wilson	1
8	A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice breakdown → 2016 ·Nature Biotechnology ·Yang Yang, Lili Wang, Peter Bell, Deirdre McMenamin, Zhenning He, John White, Hongwei Yu, Chenyu Xu, Hiroki Morizono, Kiran Musunuru, Mark L. Batshaw, James M. Wilson	433
9	Crispr/Cas9-Mediated In Vivo Gene Targeting Corrects Haemostasis in Newborn and Adult FIX-KO Mice 2016 ·Blood ·Lili Wang, Yang Yang, John White, Deirdre McMenamin, Peter Bell, James M. Wilson	3
10	Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids 2015 ·Molecular Therapy ·Lili Wang, Peter Bell, Suryanarayan Somanathan, Qiang Wang, Zhenning He, Hongwei Yu, Deirdre McMenamin, Tamara Goode, Roberto Calcedo, James M. Wilson	76
11	Biodistribution of AAV8 Vectors Expressing Human Low-Density Lipoprotein Receptor in a Mouse Model of Homozygous Familial Hypercholesterolemia 2013 ·PubMed ·Shu‐Jen Chen, Julio Sanmiguel, Martin Lock, Deirdre McMenamin, Christine Draper, Maria P. Limberis, Sadik H. Kassim, Suryanarayan Somanathan, Peter Bell, Julie Johnston, Daniel J. Rader, James M. Wilson	31
12	Cone And Rod Transduction With Alternative AAV Serotypes In The Macula Of Non-human Primates 2011 ·Investigative Ophthalmology & Visual Science ·Luk H. Vandenberghe, Peter Bell, Albert M. Maguire, Ru Xiao, Deirdre McMenamin, (unknown), Rebecca Grant, Jean Bennett, James M. Wilson	4
13	Hepatic Gene Transfer in Neonatal Mice by Adeno-Associated Virus Serotype 8 Vector 2011 ·Human Gene Therapy ·Lili Wang, Huan Wang, Peter Bell, Deirdre McMenamin, James M. Wilson	86
14	Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency reveals functional enzyme from each persisting vector genome 2011 ·Molecular Genetics and Metabolism ·Lili Wang, Hiroki Morizono, Jianping Lin, Peter Bell, David Jones, Deirdre McMenamin, Hongwei Yu, Mark L. Batshaw, James M. Wilson	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact